Skip to main content

Verification & Compliance Record

Enforcement records
Full FDA/FTC/Health Canada enforcement-records search not yet performed for Brello.
Website reachable
The listed website responded to the most recent check.

PeptideBase reports publicly documented information for educational purposes. This is not medical or legal advice, and listing does not constitute endorsement.

Are you Brello? Claim this listing to update your information and add verification.

Claim listing
Telehealth

Brello

United States
Telehealth available

No rating available

Fat LossLongevityCognitiveRecoveryPerformance

Brello is a telehealth platform that offers compounded medications including tirzepatide, semaglutide, NAD+, and sermorelin, along with lifestyle coaching and fitness classes. The service is available to women in most U.S. states and ships medications from a 503A partner pharmacy. Patients must consult with a healthcare provider and obtain a valid prescription before receiving any medication.

Visit Website
Compare provider

Peptides offered at Brello

4
Not sure which of these fit your goals? Use our research guides.

Provider Details

Coverage

Country
United States
Telehealth
Available
Regions Served
United States

Compliance

Verification & FDA Records

Commercial relationships never influence ranking, verification status, or scoring.

0 paid placements in this directory.

Report an error

Brello

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Brello changes.

Get an email when their listing details, reviews, or peptide list are updated.

PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.